Transforming Biomanufacturing: Why Architecture Must Precede Analytics

Seventy percent of digital transformation initiatives in regulated manufacturing fail to achieve their stated objectives, yet the conversation remains focused on tool selection and AI deployment. This presentation argues that the root cause is architectural, not technological: manufacturing intent, execution context, and quality evidence are lost at every lifecycle handoff — from process development to manufacturing, from site to site, from internal to CDMO. Drawing on work within the Pistoia Alliance CMC Process Ontology project and the BioPhorum Data Enablement Program, the talk introduces the concept of an Intent-Driven Digital Core — an architectural framework that preserves meaning, context, and evidence across the product lifecycle. It then demonstrates how this foundation changes what is possible: technology transfer timelines compress because receiving sites instantiate rather than reinterpret processes; batch disposition shifts from retrospective reconstruction to continuous evidence evaluation; and AI models earn regulatory trust because the data they consume has preserved semantics and provenance. The presentation closes with practical implications for MSAT and manufacturing leaders: what to invest in before investing in analytics, and how to recognize when your architecture is the bottleneck.

Presented by Martin Kockx, Principal Business Analyst & Architect in AI Systems, CMC Technology at Vertex Pharmaceuticals

Martin Kockx, PE is a manufacturing systems architect who has spent more than 15 years helping biopharmaceutical manufacturers build digital systems their organizations can actually absorb. His career runs from controls engineering and process automation through plant-wide digital programs to enterprise data architecture, across greenfield biologics facilities and cell and gene therapy operations at Genentech, Gilead, BioMarin, Thermo Fisher, Merck KGaA, and Vertex Pharmaceuticals.

At Vertex, Martin is Principal Business Analyst & Architect in AI Systems, CMC Technology, where he leads the CMC digital-foundation program spanning product lifecycle data, digital technology transfer, CMC ontology and knowledge graphs, and industrial DataOps. His core argument is that analytics and AI fail at scale when manufacturing intent, context, and evidence are lost at each lifecycle handoff — and that the fix is architectural, not algorithmic.

Martin co-authored BioPhorum’s Batch Disposition and AI-Ready Data frameworks and sits on the ISPE Boston Area Chapter Board of Directors. As a member of IAAE’s Life Science Advisory Board, he shapes upskilling pathways for manufacturing professionals moving into digitally transformed operations. He presented this argument at BioProcess International 2026 in Boston. He holds a BS in Mechanical Engineering from California State University, Sacramento.